Mesoblast (MEOBF) Share-based Compensation (2014 - 2023)

Mesoblast has disclosed Share-based Compensation across 10 years of filings, most recently posting $1.1 million for Q2 2023.

• In Q2 2023, Share-based Compensation rose 1.47% year-over-year to $1.1 million; the TTM figure through Jun 2023 stood at $3.7 million (down 33.98% YoY), while the FY2026 annual figure was $14.9 million, down 32.66% from the prior year.
• Share-based Compensation came in at $1.1 million for Q2 2023 at Mesoblast, up from $791000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.9 million in Q3 2020 to a low of $350000.0 in Q3 2022.
• Average Share-based Compensation over 5 years is $1.9 million, with a median of $1.4 million recorded in 2021.
• Year-over-year, Share-based Compensation jumped 507.09% in 2020 and sank 77.96% in 2021.
• Over 5 years, Share-based Compensation stood at $2.4 million in 2019, then soared by 44.67% to $3.5 million in 2020, then sank by 58.19% to $1.5 million in 2021, then fell by 4.93% to $1.4 million in 2022, then dropped by 21.32% to $1.1 million in 2023.
• Per Business Quant data, the three most recent Share-based Compensation figures were $1.1 million in Q2 2023, $791000.0 in Q1 2023, and $1.4 million in Q4 2022.